Cary Street Partners’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.4M Buy
10,577
+362
+4% +$134K 0.1% 215
2026
Q1
$2.76M Buy
10,215
+767
+8% +$228K 0.07% 272
2025
Q4
$3.12M Sell
9,448
-1,791
-16% -$607K 0.08% 252
2025
Q3
$3.88M Sell
11,239
-2,414
-18% -$730K 0.1% 211
2025
Q2
$4.26M Buy
13,653
+6,657
+95% +$2.54M 0.12% 186
2025
Q1
$3.66M Sell
6,996
-15,692
-69% -$8.02M 0.12% 184
2024
Q4
$11.5M Buy
+22,688
New +$12.9M 0.37% 67

Other funds holding UNH

Cary Street Partners's UNH Position: Q2 2026 in Review

Cary Street Partners increased its UnitedHealth (UNH) stake by 3.5% in Q2 2026, buying an estimated $134K and bringing the position to 10,577 shares worth $4.4M. The position accounts for 0.1% of the portfolio, ranked #215.

Cary Street Partners first reported a position in UNH in Q4 2024 and has held it in 7 quarters since. The position peaked at $11.5M in Q4 2024. 1,733 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Cary Street Partners held 10,577 shares of UnitedHealth worth $4.4M as of Q2 2026.
  • Cary Street Partners bought 362 UnitedHealth shares in Q2 2026, an estimated $134K.
  • UnitedHealth made up 0.1% of Cary Street Partners's portfolio in Q2 2026, its #215 holding.
  • Cary Street Partners first reported a position in UnitedHealth in Q4 2024 and has held it in 7 quarters since.
  • Cary Street Partners's UnitedHealth position peaked at $11.5M in Q4 2024.
  • 1,733 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.